Yes Daybue very clever. Like it.
Maybe ROW not completely over the line with Acadia but now brand name is out they might be protecting the trademark just in case.
There may be a few new players in the game now that the drug is approved and they may have pretty deep pockets. Might be an interesting week at head office this week.
In regards to TBI I’m a believer in its effectiveness and as I’ve suggested Neuren should just license it out. Why sit on the shelf gathering cob webs for years.
Could be a multi billion dollar indication on its own. May as well maximise your assets
Acadia, page-170
-
- There are more pages in this discussion • 508 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$22.14 |
Change
1.150(5.48%) |
Mkt cap ! $2.829B | |||
| Open | High | Low | Value | Volume |
| $21.50 | $22.44 | $21.50 | $13.15M | 598.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 437 | $22.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $22.15 | 8325 | 7 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |